» Articles » PMID: 2921774

Microvascular Injury in Pathogenesis of Interferon-induced Necrosis of Subcutaneous Tumors in Mice

Overview
Specialty Oncology
Date 1989 Apr 5
PMID 2921774
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

DBA/2 mice were injected sc with cells from the highly malignant Friend erythroleukemia cell (FLC) 3Cl8 subline, which is resistant to mouse interferon alpha/beta, or with the ESb lymphoma. When interferon alpha/beta was injected intratumorally or peritumorally, tumor growth was markedly suppressed, and established vascularized tumor nodules became progressively necrotic. Tumor necrosis was of the coagulation type that usually results from deprivation of blood flow. Morphologic examination of approximately 1,000 blood vessel profiles and approximately 2,000 endothelial cells in 1-micron Epon sections of sc 3C18 FLC tumors showed that interferon treatment resulted in rapid and pronounced vascular endothelial cell damage that preceded tumor necrosis. No inflammatory cell infiltrate was observed. Our results suggest that interferon alpha/beta exerted an antitumor effect in these tumor models by damaging tumor blood vessels, causing disruption of tumor blood flow, which led to ischemic tumor necrosis.

Citing Articles

Effect of Intranasal Instillation of Lipopolysaccharide on Lung Development and Its Related Mechanism in Newborn Mice.

You Y, Guo C, Zhang H, Deng S, Tang J, Xu L J Interferon Cytokine Res. 2019; 39(11):684-693.

PMID: 31268385 PMC: 6820870. DOI: 10.1089/jir.2019.0006.


Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review.

Khaddour K, Singh V, Shayuk M BMC Cancer. 2019; 19(1):449.

PMID: 31088420 PMC: 6518656. DOI: 10.1186/s12885-019-5661-x.


Effects of peritumoral bevacizumab injection against oral squamous cell carcinoma in a nude mouse xenograft model: A preliminary study.

Yoshida H, Yoshimura H, Matsuda S, Ryoke T, Kiyoshima T, Kobayashi M Oncol Lett. 2018; 15(6):8627-8634.

PMID: 29805597 PMC: 5950523. DOI: 10.3892/ol.2018.8399.


Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.

Medrano R, Hunger A, Mendonca S, Barbuto J, Strauss B Oncotarget. 2017; 8(41):71249-71284.

PMID: 29050360 PMC: 5642635. DOI: 10.18632/oncotarget.19531.


Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.

Gambichler T, Strutzmann S, Tannapfel A, Susok L BMC Cancer. 2017; 17(1):327.

PMID: 28499411 PMC: 5429577. DOI: 10.1186/s12885-017-3313-6.